Page last updated: 2024-11-02

pindolol and Acromegaly

pindolol has been researched along with Acromegaly in 1 studies

Pindolol: A moderately lipophilic beta blocker (ADRENERGIC BETA-ANTAGONISTS). It is non-cardioselective and has intrinsic sympathomimetic actions, but little membrane-stabilizing activity. (From Martindale, The Extra Pharmocopoeia, 30th ed, p638)
pindolol : A member of the class of indols which is the 2-hydroxy-3-(isopropylamino)propyl ether derivative of 1H-indol-4-ol.

Acromegaly: A condition caused by prolonged exposure to excessive HUMAN GROWTH HORMONE in adults. It is characterized by bony enlargement of the FACE; lower jaw (PROGNATHISM); hands; FEET; HEAD; and THORAX. The most common etiology is a GROWTH HORMONE-SECRETING PITUITARY ADENOMA. (From Joynt, Clinical Neurology, 1992, Ch36, pp79-80)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Passa, P1
Masquet, C1
Cophignon, J1
Gourgon, R1
Bouvrain, Y1

Other Studies

1 other study available for pindolol and Acromegaly

ArticleYear
[The heart in acromegaly. Haemodynamic study].
    Archives des maladies du coeur et des vaisseaux, 1973, Volume: 66, Issue:12

    Topics: Acromegaly; Adult; Aged; Cardiac Output; Diabetes Mellitus; Dye Dilution Technique; Female; Glucagon

1973